| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Fotios Athanasopoulos, Orionas-Vasilis Saprikis, Myrto Margeli, Christoph Klein, Nikolaos Smyrni. Towards Clinically Relevant Oculomotor Biomarkers in Early Schizophrenia. Frontiers in behavioral neuroscience. vol 15. 2021-06-29. PMID:34177483. |
in this narrative review, we focus on oculomotor function in first-episode psychosis, recent onset schizophrenia as well as individuals at high risk for developing psychosis. |
2021-06-29 |
2023-08-13 |
Not clear |
| Tesfa Dejenie Habtewold, Lyan H Rodijk, Edith J Liemburg, Grigory Sidorenkov, H Marike Boezen, Richard Bruggeman, Behrooz Z Alizade. A systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits. Translational psychiatry. vol 10. issue 1. 2021-06-18. PMID:32694510. |
a systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits. |
2021-06-18 |
2023-08-13 |
Not clear |
| Byron K Y Bitanihirwe, Tsung-Ung W Wo. A conceptualized model linking matrix metalloproteinase-9 to schizophrenia pathogenesis. Schizophrenia research. vol 218. 2021-06-17. PMID:32001079. |
in this context, the present article provides a narrative synthesis of the existing evidence linking mmp-9 dysregulation to schizophrenia pathogenesis. |
2021-06-17 |
2023-08-13 |
Not clear |
| Mohapradeep Mohan, Benjamin Ian Perry, Ponnusamy Saravanan, Swaran Preet Sing. COVID-19 in People With Schizophrenia: Potential Mechanisms Linking Schizophrenia to Poor Prognosis. Frontiers in psychiatry. vol 12. 2021-06-05. PMID:34079487. |
here, we provide a narrative on the current understanding of covid-19 in patients with schizophrenia and propose potential mechanisms which may link schizophrenia with an increased susceptibility to, and greater risk of adverse outcomes from covid-19. |
2021-06-05 |
2023-08-13 |
Not clear |
| De-Hui Ruth Zhou, Yu-Lung Marcus Chiu, Tak-Lam William Lo, Wai-Fan Alison Lo, Siu-Sing Wong, Chi Hoi Tom Leung, Chui-Kam Yu, Yuk Sing Geoffrey Chang, Kwok-Leung Lu. An unexpected visitor and a sword play: a randomized controlled trial of collective narrative therapy groups for primary carers of people with schizophrenia. Journal of mental health (Abingdon, England). 2021-05-08. PMID:32667240. |
an unexpected visitor and a sword play: a randomized controlled trial of collective narrative therapy groups for primary carers of people with schizophrenia. |
2021-05-08 |
2023-08-13 |
Not clear |
| Waldemar Kryszkowski, Tomasz Bocze. The G Protein-Coupled Glutamate Receptors as Novel Molecular Targets in Schizophrenia Treatment-A Narrative Review. Journal of clinical medicine. vol 10. issue 7. 2021-05-02. PMID:33918323. |
the g protein-coupled glutamate receptors as novel molecular targets in schizophrenia treatment-a narrative review. |
2021-05-02 |
2023-08-13 |
Not clear |
| Rikke Amalie Agergaard Jensen, Dorthe Kirkegaard Thomsen, Majse Lind, Nicolai Ladegaard, Vibeke Fuglsang Blikste. Storying the Past and the Future: Agency and Communion Themes Among Individuals With Schizophrenia and Depression. The Journal of nervous and mental disease. vol 209. issue 5. 2021-04-12. PMID:33835953. |
research has linked disturbances in narrative identity with schizophrenia and other psychiatric disorders. |
2021-04-12 |
2023-08-13 |
human |
| Rikke Amalie Agergaard Jensen, Dorthe Kirkegaard Thomsen, Majse Lind, Nicolai Ladegaard, Vibeke Fuglsang Blikste. Storying the Past and the Future: Agency and Communion Themes Among Individuals With Schizophrenia and Depression. The Journal of nervous and mental disease. vol 209. issue 5. 2021-04-12. PMID:33835953. |
the results suggest that constructing a narrative identity to foster agency and communion in both past and future chapters may be an important part of recovering from schizophrenia and depression. |
2021-04-12 |
2023-08-13 |
human |
| Tine Holm, Dorthe Kirkegaard Thomsen, Kelsey S Huling, Melanie W Fischer, Paul H Lysake. Narrative Identity, Metacognition, and Well-Being in Patients With Schizophrenia or HIV. The Journal of nervous and mental disease. vol 208. issue 12. 2021-04-02. PMID:32947451. |
narrative identity, metacognition, and well-being in patients with schizophrenia or hiv. |
2021-04-02 |
2023-08-13 |
human |
| Tine Holm, Dorthe Kirkegaard Thomsen, Kelsey S Huling, Melanie W Fischer, Paul H Lysake. Narrative Identity, Metacognition, and Well-Being in Patients With Schizophrenia or HIV. The Journal of nervous and mental disease. vol 208. issue 12. 2021-04-02. PMID:32947451. |
to study this, we measured themes of agency and communion in narrative identity in 29 individuals with schizophrenia and 29 individuals with hiv. |
2021-04-02 |
2023-08-13 |
human |
| Ben C L Yu, Winnie W S Mak, Floria H N Chi. Family involvement moderates the relationship between perceived recovery orientation of services and personal narratives among Chinese with schizophrenia in Hong Kong: a 1-year longitudinal investigation. Social psychiatry and psychiatric epidemiology. vol 56. issue 3. 2021-02-26. PMID:32797245. |
family involvement moderates the relationship between perceived recovery orientation of services and personal narratives among chinese with schizophrenia in hong kong: a 1-year longitudinal investigation. |
2021-02-26 |
2023-08-13 |
Not clear |
| Octavia O Căpățînă, Ioana V Micluția, Mihaela Fadgyas-Stănculet. Current perspectives in treating negative symptoms of schizophrenia: A narrative review (Review). Experimental and therapeutic medicine. vol 21. issue 3. 2021-02-20. PMID:33603883. |
current perspectives in treating negative symptoms of schizophrenia: a narrative review (review). |
2021-02-20 |
2023-08-13 |
Not clear |
| Piyumi Fernando, Iris E C Sommer, Alkomiet Hasa. Do we need sex-oriented clinical practice guidelines for the treatment of schizophrenia? Current opinion in psychiatry. vol 33. issue 3. 2021-02-01. PMID:32068570. |
with this narrative review, we aim to give an integrated and synthesized overview of the current state of knowledge regarding sex-specific aspects in schizophrenia and how this topic may be adapted in the development of cpgs. |
2021-02-01 |
2023-08-13 |
Not clear |
| Julia J Woo, Jennie G Pouget, Clement C Zai, James L Kenned. The complement system in schizophrenia: where are we now and what's next? Molecular psychiatry. vol 25. issue 1. 2020-11-17. PMID:31439935. |
here, we provide an up-to-date narrative review and critique of the literature on the relationship between schizophrenia and complement gene polymorphisms, gene expression, protein concentration, and pathway activity. |
2020-11-17 |
2023-08-13 |
human |
| Alexandre González-Rodríguez, Armand Guàrdia, Aida Álvarez Pedrero, Maria Betriu, Jesús Cobo, Sidharta Acebillo, José Antonio Monreal, Mary V Seeman, Diego Palao, Javier Laba. Women with Schizophrenia over the Life Span: Health Promotion, Treatment and Outcomes. International journal of environmental research and public health. vol 17. issue 15. 2020-11-13. PMID:32756418. |
the aim of this narrative review is to resolve important questions concerning the treatment of women with schizophrenia at different periods of their life-paying special attention to reproductive and post-reproductive stages. |
2020-11-13 |
2023-08-13 |
Not clear |
| Lone Baandru. Polypharmacy in schizophrenia. Basic & clinical pharmacology & toxicology. vol 126. issue 3. 2020-11-12. PMID:31908124. |
this narrative review provides a summary of the current gap between evidence and practice for use of antipsychotic combination therapy in patients with schizophrenia. |
2020-11-12 |
2023-08-13 |
Not clear |
| Alicia Lopez, Jose Re. Role of paliperidone palmitate 3-monthly in the management of schizophrenia: insights from clinical practice. Neuropsychiatric disease and treatment. vol 15. 2020-10-01. PMID:30804673. |
this narrative review aims briefly to describe the pharmacotherapeutic characteristics of pp3m and summarize current literature pertaining to the use of pp3m in the management of schizophrenia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Stefan Raue, Dirk Wedekind, Jens Wiltfang, Ulrike Schmid. The Role of Proopiomelanocortin and α-Melanocyte-Stimulating Hormone in the Metabolic Syndrome in Psychiatric Disorders: A Narrative Mini-Review. Frontiers in psychiatry. vol 10. 2020-10-01. PMID:31798479. |
here, we aim to narrow this gap in knowledge by providing a narrative review on this topic that focuses on two psychiatric diseases, namely on schizophrenia and posttraumatic stress disorder (ptsd) since we assume them to be associated with two different main causalities of mets: in schizophrenia, mets evidently develops or aggravates in response to antipsychotic drug treatment while it assumingly develops in response to stress-induced endocrine and/or epigenetic alterations in ptsd. |
2020-10-01 |
2023-08-13 |
Not clear |
| Stephen M Lawri. Are structural brain changes in schizophrenia related to antipsychotic medication? A narrative review of the evidence from a clinical perspective. Therapeutic advances in psychopharmacology. vol 8. issue 11. 2020-09-29. PMID:30344998. |
this narrative review pools evidence from observational and experimental studies in humans and animals on the relationship between antipsychotic medication use and brain structure and function in patients with schizophrenia. |
2020-09-29 |
2023-08-13 |
Not clear |
| Leslie Citrome, Joseph P McEvoy, Mark S Todtenkopf, David McDonnell, Peter J Weide. A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future. Neuropsychiatric disease and treatment. vol 15. 2020-09-29. PMID:31564881. |
the goal of this narrative is to revisit the role of oral olanzapine in the management of patients with schizophrenia, including those with recently diagnosed schizophrenia ("first-episode"), those with an established schizophrenia diagnosis who experience acute exacerbations, those receiving long-term antipsychotic treatment as a maintenance intervention, and those with suboptimal response to antipsychotic treatment, including treatment resistance. |
2020-09-29 |
2023-08-13 |
Not clear |